Belgian Medical Equipment Stock News

ENXTBR:ABI
ENXTBR:ABIBeverage

A Look At Anheuser Busch InBev (ENXTBR:ABI) Valuation After Recent Share Price Momentum

Why Anheuser-Busch InBev (ENXTBR:ABI) is back on radar Anheuser-Busch InBev (ENXTBR:ABI) has drawn fresh attention after a recent share move that leaves the stock up about 8.5% over the past month and 2.5% over the past 3 months. See our latest analysis for Anheuser-Busch InBev. For context, Anheuser-Busch InBev’s share price return is up 8.5% over the past month and 27.8% year to date, while the 1 year total shareholder return is 16.6%. This suggests momentum has been building recently. If...
ENXTBR:PROX
ENXTBR:PROXTelecom

Proximus (ENXTBR:PROX) Margin Compression Reinforces Bearish Earnings Narratives In Q1 2026

Proximus (ENXTBR:PROX) has opened 2026 with first quarter revenue of €1.5 billion and basic EPS of €0.38, alongside trailing 12 month EPS of €1.19 on revenue of €6.1 billion, setting a clear baseline for how the business is currently earning its profits. Over recent periods the company has seen quarterly revenue move from €1.67 billion in Q4 2024 to €1.63 billion in Q1 2025, then to €1.51 billion in Q1 2026, while basic EPS has shifted from €0.23 in Q4 2024 to €0.43 in Q1 2025 and €0.38 in Q1...
ENXTBR:LOTB
ENXTBR:LOTBFood

Assessing Lotus Bakeries (ENXTBR:LOTB) Valuation As New Lembeke Biscoff Hall Supports Global Growth Story

Lotus Bakeries (ENXTBR:LOTB) has begun constructing an additional production hall at its Lembeke site in Belgium to increase Biscoff output, in a move that ties directly into its push to expand the brand globally. See our latest analysis for Lotus Bakeries. The construction update comes as the stock shows strong momentum, with a 30.9% year-to-date share price return and a 22.57% one-year total shareholder return, while the five-year total shareholder return of 136.72% reflects sustained...
ENXTBR:ECONB
ENXTBR:ECONBIT

Econocom Group And 2 European Small Caps With Promising Potential

In recent weeks, the pan-European STOXX Europe 600 Index has experienced modest gains amid easing geopolitical tensions and robust corporate earnings, though market sentiment remains cautious due to potential U.S. tariff threats on EU goods. Against this backdrop of fluctuating market conditions, identifying promising small-cap stocks requires a keen eye for companies with strong fundamentals and growth potential that can navigate economic uncertainties effectively.
ENXTBR:PROX
ENXTBR:PROXTelecom

Will Weaker Q1 2026 Earnings Momentum Change Proximus' (ENXTBR:PROX) Investment Narrative?

Proximus PLC has reported past first-quarter 2026 results showing sales of €1,510 million and revenue of €1,525 million, with net income of €124 million and basic earnings per share from continuing operations of €0.38, all lower than the same period a year earlier. This broad-based decline across sales, revenue and earnings measures raises questions about how effectively Proximus’s existing efficiency programs and investment plans are offsetting current pressures on its business. We’ll now...
ENXTBR:VGP
ENXTBR:VGPReal Estate

Assessing VGP (ENXTBR:VGP) Valuation After Recent Share Price Weakness

Recent share performance and business context VGP (ENXTBR:VGP) has drawn investor attention after the stock declined 10.2% over the past day, extending falls of 5.6% over the past week and 11.3% over the past month. Those moves come as the €2.21b logistics and semi industrial real estate company, headquartered in Antwerp, continues to generate revenue of €191.99m and net income of €290.44m. This performance is partly supported by its renewable energy activities. See our latest analysis for...
ENXTBR:VIO
ENXTBR:VIOMetals and Mining

Assessing Viohalco (ENXTBR:VIO) Valuation After Investor Interest In Its Diversified Metals And Cables Operations

Viohalco (ENXTBR:VIO) drew attention after its stock climbed 13.55% in after-hours trading on EURONEXT on 7 May, as investors focused on its aluminium, copper, cables, and steel operations. See our latest analysis for Viohalco. That after hours jump adds to strong recent momentum, with a 7 day share price return of 16.45% and a 30 day share price return of 23.60%. The 1 year total shareholder return of 218.26% and 5 year total shareholder return of 288.09% underline how sentiment has shifted...
ENXTBR:KBCA
ENXTBR:KBCABanks

Assessing KBC Ancora (ENXTBR:KBCA) Valuation After Recent Mixed Share Price Performance

Recent returns and what they might mean for investors KBC Ancora (ENXTBR:KBCA) has quietly posted mixed share price moves, with a 0.6% decline over the past day, a 2.2% gain over the past week, and around 4.5% over the past month. For longer term holders, the stock shows a modest gain of about 0.3% over the past 3 months, alongside a year to date return of roughly 5.4% and a 1 year total return close to 38.3%. See our latest analysis for KBC Ancora. With the share price at €79.4, KBC Ancora...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Argenx Leadership Shift And Vyvgart Milestones Reshape Autoimmune Growth Story

argenx (ENXTBR:ARGX) appointed Karen Massey as CEO, and co founder Tim Van Hauwermeiren moved to Chairperson. The company reported strong Q1 results, with accelerating VYVGART sales highlighted as a key driver. An FDA decision on a potential Vyvgart label expansion in seronegative generalized myasthenia gravis is expected soon. argenx focuses on antibody based therapies for autoimmune diseases, with VYVGART already a central product in its portfolio. For investors watching the immunology...
ENXTBR:SYENS
ENXTBR:SYENSChemicals

Syensqo Share Cancellation Reshapes Ownership As Valuation Gap Persists

Syensqo cancelled a significant number of shares it had repurchased as part of its ongoing buyback program. The move changes the total number of outstanding shares and voting rights for ENXTBR:SYENS. The action forms part of a broader capital management approach that affects how ownership is distributed across shareholders. For investors watching ENXTBR:SYENS, the cancellation of repurchased shares directly alters the share count that sits behind the current €57.3 price. Recent performance...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Solvay (ENXTBR:SOLB) Q1 Profit Of €26 Million Tests Loss-Making Narrative

Solvay (ENXTBR:SOLB) opened 2026 with Q1 revenue of €1.1 billion and basic EPS of €0.25, alongside trailing twelve month revenue of €4.6 billion and a basic EPS loss of €0.24, setting a mixed backdrop for the latest results. Over recent quarters the company has seen revenue range between €1.1 billion and €1.3 billion per quarter, with basic EPS moving from €0.78 in Q1 2025 through several smaller profits and a loss of €0.90 in Q4 2025 before rebounding in Q1 2026, leaving investors focused on...
ENXTBR:ABI
ENXTBR:ABIBeverage

Anheuser-Busch InBev (ENXTBR:ABI) Margin Stability Supports Bullish Long Term Growth Narratives

Anheuser-Busch InBev (ENXTBR:ABI) opened 2026 with Q1 revenue of US$15.3b and basic EPS of US$1.30, setting a clear benchmark for how the rest of the year might shape up for the brewer’s top and bottom lines. The company has seen quarterly revenue move from US$13.6b in Q1 2025 to US$15.3b in Q1 2026, while basic EPS shifted from US$1.08 to US$1.30 over the same period. This gives you a clean read on how sales and per share earnings are tracking through the cycle. With that backdrop, the...
ENXTBR:COFB
ENXTBR:COFBHealth Care REITs

A Look At Cofinimmo (ENXTBR:COFB) Valuation After Q1 Earnings Reveal Higher Sales And Lower Net Income

Earnings snapshot and why it matters now Cofinimmo (ENXTBR:COFB) has just reported first quarter 2026 results, with sales of €87.31 million compared with €86.81 million a year earlier, while net income came in at €53.51 million versus €64.26 million. This mix of slightly higher sales and lower profitability is giving investors fresh numbers to reassess the stock, especially following the recent share price moves over the past month and over the past three months. See our latest analysis for...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Is It Time To Reassess argenx (ENXTBR:ARGX) After Its Strong Multi Year Run?

Investors may be wondering whether argenx at €678.60 is offering fair value or carrying a premium, particularly after its strong long term share price record. The stock has returned 2.0% over the last 7 days, 4.9% over the last 30 days, a 6.2% decline year to date and 19.8% over the last year, with longer term returns of 86.7% over 3 years and 220.1% over 5 years. Recent coverage around argenx has focused on its position in the biotech sector and investor debate around how much future growth...
ENXTBR:XIOR
ENXTBR:XIORResidential REITs

A Look At Xior Student Housing (ENXTBR:XIOR) Valuation After Its Stronger First Quarter Results

Why Xior’s latest quarterly results matter for investors Xior Student Housing (ENXTBR:XIOR) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of €48.67 million and net income of €48.6 million, compared with €43.88 million and €41.95 million a year earlier. See our latest analysis for Xior Student Housing. Despite the stronger first quarter figures, the share price is at €27.6, with a 1 day share price return of 0.91% but a 1 year total shareholder return of...
ENXTBR:UMI
ENXTBR:UMIChemicals

Umicore Leadership Shakeup Puts Digital Transformation And Execution In Focus

Umicore (ENXTBR:UMI) has appointed Lily Liu as Chief Financial Officer and Executive Vice President. The company is also creating a new Chief Digital & Transformation Officer role to focus on digitalization and operational excellence. These leadership changes reflect a shift in how Umicore organizes its executive team and oversees transformation initiatives. For investors watching ENXTBR:UMI, the leadership reshuffle comes with the stock at €17.18 and a mixed return profile. The share price...
ENXTBR:ABI
ENXTBR:ABIBeverage

Dividend Hike and Board Refresh Could Be A Game Changer For Anheuser-Busch InBev (ENXTBR:ABI)

At its 29 April 2026 shareholder meeting, Anheuser-Busch InBev approved a €1.15 gross total dividend for 2025 and refreshed its board, appointing Fabrizio Freda and Miguel Patricio as directors alongside new Restricted Share Directors. Coupled with a planned US$600.00 million investment in U.S. manufacturing and workforce training, these moves highlight AB InBev’s focus on strengthening operations and supporting shareholder returns. Next, we’ll examine how AB InBev’s newly approved...
ENXTBR:AGS
ENXTBR:AGSInsurance

Ageas Tightens Grip On Belgium While Eyeing India Growth And Valuation

ageas (ENXTBR:AGS) has completed the acquisition of the remaining stake in AG Insurance, consolidating full ownership of its Belgian insurance business. The company has issued new and treasury shares to BNP Paribas Cardif, increasing its outstanding share capital and reshaping its shareholder base. ageas is accelerating expansion in India, aiming for a top 10 position through acquisitions and deeper bancassurance partnerships. For investors watching ENXTBR:AGS, these moves come as the share...